Huifang Su

机构：First Affiliated Hospital of Zhengzhou University, Nanjing University · ORCID：0000-0001-6298-0583

发表论文 137 篇 · 总被引 6339 次 · h-index 43

代表论文

• Recent advances in senescence-associated secretory phenotype and osteoporosis (2024 · Heliyon · 被引 37)
• Organic Radiosensitizer with Aggregation-Induced Emission Characteristics for Tumor Ablation through Synergistic Apoptosis and Immunogenic Cell Death (2025 · ACS Nano · 被引 26)
• Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis (2024 · Theranostics · 被引 24)
• Near‐Infrared II AIE Luminogens with Mitochondria‐Targeting Characteristics for Combinational Phototherapies of Breast Tumors Through Synergistic Cell Apoptosis and Pyroptosis (2024 · Advanced Functional Materials · 被引 19)
• Dual-organelle targeted photosensitizer with AIE characteristics for triple-negative breast cancer photodynamic therapy via apoptosis and immunogenic cell death (2025 · Materials Today Bio · 被引 16)
• Molecularly manipulating pyrazinoquinoxaline derivatives to construct NIR-II AIEgens for multimodal phototheranostics of breast cancer bone metastases (2025 · Biomaterials · 被引 15)